• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗患者前列腺特异性抗原检测自我报告的准确性。

The accuracy of primary care patients' self-reports of prostate-specific antigen testing.

作者信息

Volk Robert J, Cass Alvah R

机构信息

Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77005, USA.

出版信息

Am J Prev Med. 2002 Jan;22(1):56-8. doi: 10.1016/s0749-3797(01)00397-x.

DOI:10.1016/s0749-3797(01)00397-x
PMID:11777680
Abstract

BACKGROUND

The accuracy of reports made by male primary care patients of previous screening for prostate cancer with the prostate-specific antigen (PSA) assay is important for clinical practice, surveillance, and research.

METHODS

As part of a clinical trial that evaluated a decision aid for prostate cancer screening, 133 male primary care patients, aged 45 to 70 years, were contacted 1 year after enrollment and asked whether they had received PSA testing. To corroborate these self-reports, each patient's clinic and hospital medical records were reviewed for evidence of PSA test results.

RESULTS

The raw percentage agreement between self-reported PSA testing and the medical records was 74.4% (kappa=0.48). When compared to the findings of the medical record reviews, apparent overreporting by some patients was explained by problems with recalling the test within the 1-year time frame (4.5%) and by having been tested outside of the medical center (5.3%). Uncertainty about having been tested was reported by six (4.5%) patients with PSA test results in their medical records. Misreported testing could not be explained for 11.3% of patients. Patients who had not completed high school were 2.7 times more likely to misreport PSA testing (95% confidence interval, 1.61-3.87).

CONCLUSIONS

The accuracy of primary care patients' self-reports of previous PSA testing is questionable. Errors in reporting are due largely to problems with recalling a test within a specific time frame or to testing outside of the primary care setting. Under-reporting is a problem for patients uncertain of previous testing.

摘要

背景

男性初级保健患者关于既往前列腺特异性抗原(PSA)检测筛查前列腺癌报告的准确性,对于临床实践、监测及研究均具有重要意义。

方法

作为一项评估前列腺癌筛查决策辅助工具的临床试验的一部分,133名年龄在45至70岁之间的男性初级保健患者在入组1年后接受随访,询问他们是否接受过PSA检测。为证实这些自我报告,查阅了每位患者的诊所及医院病历,以获取PSA检测结果的证据。

结果

自我报告的PSA检测与病历之间的原始百分比一致性为74.4%(kappa=0.48)。与病历审查结果相比,部分患者明显的报告过度可归因于在1年时间范围内回忆检测存在问题(4.5%)以及在医疗中心以外接受检测(5.3%)。6名(4.5%)病历中有PSA检测结果的患者报告了对是否接受过检测存在不确定性。11.3%的患者无法解释报告错误的情况。未完成高中学业的患者错误报告PSA检测的可能性高出2.7倍(95%置信区间,1.61 - 3.87)。

结论

初级保健患者既往PSA检测自我报告的准确性存疑。报告错误主要归因于在特定时间范围内回忆检测存在问题或在初级保健机构以外接受检测。对于不确定既往检测情况的患者,报告不足是一个问题。

相似文献

1
The accuracy of primary care patients' self-reports of prostate-specific antigen testing.基层医疗患者前列腺特异性抗原检测自我报告的准确性。
Am J Prev Med. 2002 Jan;22(1):56-8. doi: 10.1016/s0749-3797(01)00397-x.
2
Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.安大略省的前列腺特异性抗原检测:对未确诊前列腺癌患者进行检测的原因
CMAJ. 1999 Jan 12;160(1):70-5.
3
The validity of male patients' self-reports regarding prostate cancer screening.男性患者关于前列腺癌筛查自我报告的有效性。
Prev Med. 1999 Mar;28(3):297-303. doi: 10.1006/pmed.1998.0430.
4
Factors influencing use of the prostate-specific antigen screening test in primary care.影响基层医疗中前列腺特异性抗原筛查试验使用的因素。
Am J Manag Care. 2000 Mar;6(3):315-24.
5
Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?使用前列腺特异性抗原检测筛查前列腺癌:患者是否在做出明智的决策?
J Fam Pract. 1999 Sep;48(9):682-8.
6
Prostate cancer screening practices in a large, integrated health system: 2007-2014.大型综合医疗系统中的前列腺癌筛查实践:2007 - 2014年
BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26.
7
Use of prostate-specific antigen for prostate cancer screening in primary care practice.在基层医疗实践中使用前列腺特异性抗原进行前列腺癌筛查。
Arch Fam Med. 1995 Apr;4(4):311-5. doi: 10.1001/archfami.4.4.311.
8
Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.影响初级保健医生决定为无前列腺癌男性开具前列腺特异性抗原(PSA)检测的因素。
Acta Oncol. 2013 Nov;52(8):1602-8. doi: 10.3109/0284186X.2012.762998. Epub 2013 Feb 19.
9
High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.在有良性前列腺增生证据的男性中,前列腺特异性抗原检测率较高。
Am J Med. 1998 Jun;104(6):517-25. doi: 10.1016/s0002-9343(98)00113-2.
10
Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).前列腺癌筛查决策:全国医疗决策调查(DECISIONS研究)结果
Arch Intern Med. 2009 Sep 28;169(17):1611-8. doi: 10.1001/archinternmed.2009.262.

引用本文的文献

1
Barbershop Prostate Cancer Education: Factors Associated With Client Knowledge.理发店前列腺癌教育:与顾客知识相关的因素
Am J Mens Health. 2017 Sep;11(5):1415-1425. doi: 10.1177/1557988315607958.
2
Barbershop Prostate Cancer Education: Factors Associated With Client Knowledge.理发店前列腺癌教育:与顾客知识相关的因素
Am J Mens Health. 2017 Jan;11(1):116-125. doi: 10.1177/1557988316632979. Epub 2016 Jun 22.
3
Predicting Incongruence between Self-reported and Documented Colorectal Cancer Screening in a Sample of African American Medicare Recipients.
预测非裔美国医疗保险受益人群样本中自我报告与记录的结直肠癌筛查之间的不一致情况。
Behav Med. 2016 Oct-Dec;42(4):238-47. doi: 10.1080/08964289.2015.1011600. Epub 2015 May 11.
4
Beyond the black box: a systematic review of breast, prostate, colorectal, and cervical screening among native and immigrant African-descent Caribbean populations.超越黑匣子:对非洲裔加勒比本土和移民人群中乳腺癌、前列腺癌、结直肠癌和宫颈癌筛查的系统评价
J Immigr Minor Health. 2015 Jun;17(3):905-24. doi: 10.1007/s10903-014-9991-0.
5
African american primary care physicians' prostate cancer screening practices.非裔美国初级保健医生的前列腺癌筛查实践。
J Prim Care Community Health. 2014 Jan 1;5(1):36-43. doi: 10.1177/2150131913507454. Epub 2013 Oct 17.
6
National evidence on the use of shared decision making in prostate-specific antigen screening.国家关于在前列腺特异性抗原筛查中使用共同决策的证据。
Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.
7
Behind Closed Doors: What Happens when Patients and Providers Talk about Prostate-Specific Antigen Screening?: Survey of the Effects of a Community-Based Intervention.闭门会议:医患讨论前列腺特异性抗原筛查时会发生什么?:一项基于社区的干预措施效果调查。
Patient. 2009 Sep 1;2(3):191-201. doi: 10.2165/11312730-000000000-00000.
8
Discussions about prostate cancer screening between U.S. primary care physicians and their patients.美国初级保健医生及其患者之间关于前列腺癌筛查的讨论。
J Gen Intern Med. 2011 Oct;26(10):1098-104. doi: 10.1007/s11606-011-1682-0. Epub 2011 Mar 18.
9
Trends in prostate-specific antigen test use, 2000-2005.2000-2005 年前列腺特异性抗原检测的使用趋势。
Public Health Rep. 2011 Mar-Apr;126(2):228-39. doi: 10.1177/003335491112600214.
10
Translating medical evidence to promote informed health care decisions.将医学证据转化为促进明智的医疗保健决策。
Health Serv Res. 2011 Aug;46(4):1200-23. doi: 10.1111/j.1475-6773.2011.01248.x. Epub 2011 Feb 25.